Hereditary Haemochromatosis: NNC0614-0001 Study

We are evaluating the effects of a new treatment in healthy adults and individuals with hereditary haemochromatosis type 1. This research aims to understand how the treatment works in these groups.

>2 yearsSafety phase (I)HematologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University Of Graz
Department of Internal Medicine
Graz, Austria
Sponsor: Novo Nordisk A/S
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.